Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases

Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases

Establishing a definitive diagnosis of Cushing disease (CD), given its clinical and biochemical heterogeneity, initiating effective treatment to control the effects of hypercortisolism, and managing recurrence are challenging disease aspects to address. Mifepristone is a competitive glucocorticoid r...

Full description

Bibliographic Details
Main Authors: Alice Y Chang, Sasan Mirfakhraee, Elizabeth E King, Jennifer U Mercado, Diane M Donegan, Kevin CJ Yuen
Format: Article
Language:English
Published: SAGE Publishing 2021-02-01
Series:Clinical Medicine Insights: Endocrinology and Diabetes
Online Access:https://doi.org/10.1177/1179551421994102

Similar Items

Similar Items